Dr. Michael J Fisher, MD
Claim this profileChildren's Hospital of Philadelphia
About Michael J Fisher, MD
Education:
- MD from the University of Pennsylvania Perelman School of Medicine, 2015.
- Completed Residency in Pediatrics at the Children's Hospital of Philadelphia, 2018.
- Fellowship in Pediatric Cardiology at the Children's Hospital of Philadelphia, 2021.
Experience:
- Practicing pediatric cardiologist at the Children's Hospital of Philadelphia.
Area of expertise
Brain Tumor
Michael J Fisher, MD has run 13 trials for Brain Tumor. Some of their research focus areas include:
Diffuse Intrinsic Pontine Glioma
Michael J Fisher, MD has run 7 trials for Diffuse Intrinsic Pontine Glioma. Some of their research focus areas include:
Affiliated Hospitals
Children's Hospital Of Philadelphia
The Children's Hospital Of Philadelphia
Clinical Trials Michael J Fisher, MD is currently running
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting
2 awards
Phase 3
Ribociclib + Everolimus
for Brain Tumors
This trial is testing whether the combination of ribociclib and everolimus can help children and young adults with aggressive brain tumors live longer. Everolimus is a medication that has been approved for treating various cancers. These drugs are taken by mouth and work by stopping cancer cells from growing. The study focuses on patients whose tumors have specific genetic changes that make them hard to treat with standard therapies.
Recruiting
1 award
Phase 2
More about Michael J Fisher, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 10 Active Clinical Trials
Treatments Michael J Fisher, MD has experience with
- Selumetinib
- Radiotherapy
- PTC596
- Larotrectinib Surgical
- Larotrectinib
- PEP-CMV Vaccine
Breakdown of trials Michael J Fisher, MD has run
Brain Tumor
Diffuse Intrinsic Pontine Glioma
Brain Cancer
Low Grade Glioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael J Fisher, MD specialize in?
Michael J Fisher, MD focuses on Brain Tumor and Diffuse Intrinsic Pontine Glioma. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are NTRK positive.
Is Michael J Fisher, MD currently recruiting for clinical trials?
Yes, Michael J Fisher, MD is currently recruiting for 10 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Michael J Fisher, MD has studied deeply?
Yes, Michael J Fisher, MD has studied treatments such as Selumetinib, Radiotherapy, PTC596.
What is the best way to schedule an appointment with Michael J Fisher, MD?
Apply for one of the trials that Michael J Fisher, MD is conducting.
What is the office address of Michael J Fisher, MD?
The office of Michael J Fisher, MD is located at: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the Children's Hospital of Philadelphia.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.